Since the onset of the COVID-19 pandemic, Fresh-Aire UV has been providing UV system recommendations for residential, educational, commercial and healthcare facilities.
Fresh-Aire UV, a world-leader in HVAC ultraviolet disinfection systems, has successfully completed phase-1 third-party testing of their residential, commercial, and healthcare products for effectiveness against SARS-CoV-2 (the virus that causes COVID-19 disease). In the test report titled “SARS-CoV-2 Neutralization by Germicidal UV Light System from FreshAire UV” the systems delivered greater than 4-log inactivation (>99.99%) on the SARS-CoV-2 virus within 0-2 seconds of exposure to Fresh-Aire UV UVC 254nm light systems.
According to Aaron Engel, Vice-President of Business Development at Fresh-Aire UV: “Fresh-Aire UV has been manufacturing proprietary germicidal UV systems for 20 years, and with everything we know about the SARS-CoV-2 virus combined with our testing experience, we were confident our systems would be very effective at inactivating the virus. We now have independent verification of the successful inactivation of the SARS COVID-19 virus and an even better understanding of how well our disinfection systems perform within the HVAC system, duct work and on surfaces. We are thrilled.”
Fresh-Aire UV is recognized the world over as a leader in the areas of UV light disinfection and indoor air quality. Our products reduce indoor air pollution, sterilize viruses, bacteria, and mold, neutralize odors and VOCs, and provide chemical-free air and surface disinfection. Fresh-Aire UV is the innovation leader with numerous patents and industry awards, including the AHR Innovation Award for Indoor Air Quality for 2011 and 2020.
Fresh-Aire UV systems are not intended to diagnose, treat, prevent, or cure any disease. Fresh-Aire UV systems have been tested on SARS-CoV-2, isolate USA-WA1/2020.